The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma

The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma

Abstract Background Esophageal squamous cell carcinoma (ESCC) is the most difficult subtype of esophageal cancer to treat due to the paucity of effective targeted therapy. ESCC is believed to arise from cancer stem cells (CSCs) that contribute to metastasis and chemoresistance. Despite advances in d...

Full description

Bibliographic Details
Main Authors:	Yue Zhao, Ji Zhu, Bowen Shi, Xinyu Wang, Qijue Lu, Chunguang Li, Hezhong Chen
Format:	Article
Language:	English
Published:	BMC 2019-07-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	OV6 Lymphoid enhancer-binding factor 1 (LEF1) Esophageal squamous cell carcinoma (ESCC) Prognosis CSC-like phenotype
Online Access:	http://link.springer.com/article/10.1186/s13046-019-1296-7

Similar Items

Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma
by: Min-Cheng Su, et al.
Published: (2014-12-01)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021-11-01)

Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient
by: Qijue Lu, et al.
Published: (2020-03-01)

AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis
by: Yuan Mi, et al.
Published: (2024-04-01)

Interpretation of “Novelty” in the Theory of Russian Avant-guard (“LEF”, “Novy LEF”)
by: Aleksandr A. Zhitenev
Published: (2019-09-01)

Microarray Analysis of Radioresistance-associated Genes in Esophageal Squamous Cell Carcinoma
by: ZHU Qingshan, et al.
Published: (2019-03-01)

Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β‐catenin signaling pathway
by: Yun‐Long Zhao, et al.
Published: (2019-01-01)

The Single Nucleotide Polymorphisms of AP1S1 are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population
by: Su F, et al.
Published: (2022-03-01)

The protective mechanism of SIRT1 on cartilage through regulation of LEF-1
by: Xueyu Hu, et al.
Published: (2021-07-01)

Prevalence and Association of Human Papillomavirus with Esophageal Squamous Cell Carcinoma in Iran: A Systematic Review and Meta-Analysis
by: Bashir MOHAMMADPOUR, et al.
Published: (2019-07-01)

Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1
by: Geon-Hee Kim, et al.
Published: (2020-09-01)

Evaluation of serum level of lymphoid enhancer-binding factor-1 and its relation with clinico-hematological and prognostic parameters in pediatric patients with acute lymphoblastic leukemia
by: Zeena Tariq Ahmed, et al.
Published: (2022-01-01)

Occupational risks of esophageal cancer in Taiwanese men
by: Shih-Hui Huang, et al.
Published: (2012-12-01)

Absence of mutations in the promoter region of the lef1 gene in Patients with hypodontia
by: Elisângela R. Silva, et al.
Published: (2015-11-01)

Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected
by: Chenxi Ju, et al.
Published: (2022-06-01)

Clinical value of station 4R node dissection in esophageal squamous cell carcinoma
by: Xin-ye Wang, et al.
Published: (2023-12-01)

Drug repositioning for esophageal squamous cell carcinoma
by: Adam N. Bennett, et al.
Published: (2022-09-01)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
by: Lingzhao Li, et al.
Published: (2022-07-01)

Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration
by: Jiefei Xiao, et al.
Published: (2018-10-01)

Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis
by: Zehua Zhang, et al.
Published: (2022-08-01)

Quercetin Inhibits Lef1 and Resensitizes Docetaxel-Resistant Breast Cancer Cells
by: Marta Prieto-Vila, et al.
Published: (2020-06-01)

Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation
by: Zhongjian Chen, et al.
Published: (2021-08-01)

Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma
by: Jiecheng Ye, et al.
Published: (2021-10-01)

LEF1-AS1, a Long Non-Coding RNA, Promotes Malignancy in Glioblastoma [Retraction]
by: Wang J, et al.
Published: (2024-01-01)

CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells
by: Javed Akhtar, et al.
Published: (2023-09-01)

Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
by: Zhe Zhang, et al.
Published: (2023-04-01)

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
by: Qiubo Xie, et al.
Published: (2020-07-01)

Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma
by: Bingyan Liu, et al.
Published: (2016-07-01)

Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
by: Minqi Zhu, et al.
Published: (2022-09-01)

circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling
by: Xueting Hu, et al.
Published: (2019-11-01)

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
by: Hansheng Wu, et al.
Published: (2021-05-01)

Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights
by: Stavros P. Papadakos, et al.
Published: (2024-03-01)

Immunohistochemical staining of LEF-1 is a useful marker for distinguishing WNT-activated medulloblastomas
by: Depeng Wang, et al.
Published: (2022-09-01)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
by: Chengzhi Ding, et al.
Published: (2023-12-01)

Abdominal lymph node metastasis in non-surgical esophageal squamous cell carcinoma: prognostic significance and a novel staging strategy
by: Zongxing Zhao, et al.
Published: (2023-10-01)

Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma
by: Xian-Zi Yang, et al.
Published: (2018-07-01)

Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
by: Shuying Yin, et al.
Published: (2020-05-01)

LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway
by: Weiyuan Li, et al.
Published: (2020-11-01)

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
by: Qi Song, et al.
Published: (2021-09-01)

Metabolomic transition trajectory and potential mechanisms of N-nitrosomethylbenzylamine induced esophageal squamous cell carcinoma in rats
by: Chao Zhao, et al.
Published: (2022-10-01)